LONG-TERM FOLLOW-UP STUDY OF JUVENILE DIFFERENTIATED THYROID CARCINOMA TREATED BY RADIOACTIVE IODINE

The overall prognosis in pediatric differentiated thyroid carcinoma (DTC) is excellent. Recurrent disease is frequent, however, and requires additional treatment. In this study we retrospectively analyzed the outcome of juvenile DTC treated by radioactive iodine (I-131) during the long-term follow-up study of 29 years. Methods: 54 DTC patients (34 females, 20 males; ≤20 years old, mean age, 16,5 years) were treated with 131I (RAI) with a median follow-up of 13 years. Patients (pts) underwent different initial treatment: 49 pts, TTx+RAI; 2 pts, TTx; and 3 pts, STTx. The probability of recurrence and prognostic factors were tested by Kaplan-Meier’s method. Results: Initially, 37/54 pts achieved complete remission (CR), 16/54 pts partial remission (PR), 1/54 had progressive disease (PG). During the follow-up 11 pts (20,4%) who achieved CR developed recurrent disease (RD); median appearance time, 4 years (range, 1–25 years). Probability of recurrence was 15,8% at 5 years; 20,3% at 10 years, 25,6% at 15, 20 and 26 years after initial treatment. Strong predictive factors of recurrence were age (p=0,0001), initial treatment (p=0,0001), and tumor multifocality (p=0,004), while gender, nodal metastases at presentation, distal metastases at presentation, histological type of the tumor, tumor or T stage and clinical stage showed no influence on relapse (p=0,176; p=0,757; p=0,799; and p=0,822, respectively). Patients with RD, PR and PG were retreated, with surgery or surgery plus RAI, receiving cumulative activity up to 40 GBq. The overall outcome in our patients was excellent: 88,9% CR, 5,55% SD, 1,85% PG, 1,85% DRD, and 1,85% OCD. Conclusion: Younger age at diagnosis, less radical primary surgery without subsequent RAI, and tumor multifocality are strong prognostic factors for recurrence. In order to reduce relapse rate and to improve surveillance for recurrent disease, TTx followed by RAI appears to be the most beneficial initial treatment for patients with juvenile DTC. The use of RAI seems to be safe without adverse effects on subsequent fertility and pregnancy or secondary malignancy.

1. Hung W., Sarlis N.J. Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review. Thyroid. 2002. Vol. 12. Р. 683–702.

2. Ries L.A.G., Melbert D., Krapcho M. et al., eds. SEER Cancer Statistics Review, 1975–2004. Bethesda: National Cancer Institute. 2007. Based on November 2006 SEER data submission.

3. www.batut.org.rs. Cancer Incidence and mortality in central Serbia-available on July, 6th 2013.

4. Cancer registry data of Vojvodina Institute of oncology, 2010.

5. Giuffrida D., Scollo, Pellegriti G. et al. Differentiated thyroid cancer in children and adolescents // J. Endocrinol. Invest. 2002. Vol. 25. Р. 18–24.

6. Zimmerman D. et al. Papillary thyroid cancer in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades // Surgery. 1988. Vol. 104. Р. 1157–1166.

7. Brink J.S., van Heerden J.A., McIver B. et al. Papillary thyroid cancer with pulmonary metastases in children: long term prognosis // Surgery. 2000. Vol. 128. Р. 881–886.

8. Hogan A.R., Zhuge Y., Perez E.A. et al. Pediatric thyroid carcinoma: incidence and outcome in 1753 patients // J. Surg. Res. 2009. Vol. 156 (1). Р. 167–172.

9. Newman K.D. et al. Differentiated thyroid cancer: determinants of disease progression in patients 31. Lin J.D., Chao T.C., Hsueh C., Kuo S.F. High recurrent rate of multicentric papillary thyroid carcinoma // Ann. Surg. Oncol. 2009. Vol. 16. Р. 2609–2616.

10. Welch Dinauer C.A., Tuttle R.M., Robie D.K. et al. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults // Clin. Endocrinol (Oxf). 1998. Vol. 49. Р. 619–628.

11. Grigsby P.W., Gal-or A., Michalsky J.M. et al. Childhood adolescent thyroid carcinoma // Cancer. 2002. Vol. 95. Р. 724–729.

12. Hay I.D., Gonzalez-Losada T., Reinalda M.S. et al. Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J. Surg. 2010. Vol. 34. Р. 1192–1202.

13. Sobin L.H., Gospodarowicz M.K., Wittekind C. UICC TNM Classification of Malignant Tumours. 7th ed. West Sussex, England: Blackwell Publishing. 2010. Р. 58–62.

14. Bernstein L., Gurney J.G. Carcinomas and other malignant epithelial neoplasms. ICCC XI. Pediatric Monograph, NCI SEER, 2001.

15. Huang C.H., Chao T.C., Hseuh C. et al. Therapeutic outcome and prognosis in young patients with papillary and follicular thyroid cancer. Pediatr Surg Int. 2012. Vol. 28. Р. 489–494.

16. Enomoto Y., Enomoto E., Uchino S. et al. Clinical features, treatment, and long-term outcome of papillary thyroid cancer in children and adolescents without radiation exposure // World J. Surg. 2012. Vol. 36. Р. 1241–1246.

17. Papendieck P., Grunero-Papendieck L., Venara M. et al. Differentiated thyroid carcinoma: presentation and follow-up in children and adolescents // J. Pediatr. Endocr. Met. 2011. Vol. 24. Р. 743–748.

18. Popovtzer A., Shpitzer T., Bahar G., Feinmesser R., Segal K. Thyroid cancer in children: Management and outcome experience of a referral center // Otolaryngol. Head Neck Surg. 2006. Vol. 135. Р. 581–584.

19. Handkiewicz-Junak D., Wloch J., Roskosz J. et al. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer // J. Nucl. Med. 2007. Vol. 48. Р. 879.

20. Demidchik Y.E., Demidchik E.P., Reiners C. et al. Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus // Ann. Surg. 2006. Vol. 243. Р. 525–532.

21. Lazar L., Lebenthal Y., Steinmetz A., Yackobovitch-Gavan M., Phillip M. Differentiated thyroid carcinoma in pediatric patients: comparison of presentation and course between pre-pubertal children and adolescents // J. Pediatr. 2009. Vol. 154. Р. 708–714.

22. Dardas M, Salti I, Sabri A, et al. Thyroid cancer in Lebanese children and adolescent: 1 15-year experience at a single institution. Pediatr Hematol Oncol. 2009. Vol. 26. Р. 439–447.

23. Landau D., Vini L., A’Hern R., Harmer C. Thyroid cancer in children: the Royal Marsden Hospital experience // Eur. J. Cancer. 2000. Vol. 36. Р. 214–220.

24. Alessandri A.J., Goddard K.J., Blair G.K. et al. Age is the major determinant of recurrence in pediatric differentiated thyroid carcinoma // Med. Pediatr. Oncol. 2000. Vol. 53. Р. 41–46.

25. Farahati J., Bucsky P., Parlowsky T., Mader U., Reiners C. Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology // Cancer. 1997. Vol. 80. Р. 2156–2161.

26. LaQuardia M.P., Corbally M.T., Heller G. et al. Recurrence and morbidity in differentiated thyroid cancer in children // Surgery. 1998. Vol. 104. Р. 1149–1156.

27. Jazarb B., Handkiewitz-Junak D.H., Wloch J. et al. Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children // Eur. J. Nucl. Med. 2000. Vol. 27. Р. 833–841.

28. Palmer B.A., Zarroug A.E., Poley R.N., Kollars J.P., Moir C.R. Papillary thyroid carcinoma in children: risk factors and complications of disease recurrence // J. Pediatr. Surg. 2005. Vol. 40. Р. 1284–1288.

29. Spinelli C., Bertocchini A., Antonelli A. et al. Surgical therapy of the thyroid papillary carcinoma in children: Experience with 56 patients ≤16 years old // J. Pediatr. Surg. 2004. Vol. 39. Р. 1500.

30. Borson-Chazot F., Causeret S., Lifante J.C., Augros M., Berger N., Peix J.L. Predictive factors for recurrence from a series of 74 children and adolescents with differentiated thyroid cancer // World J. Surg. 2004. Vol. 28. Р. 1088–1092.

31. Lin J.D., Chao T.C., Hsueh C., Kuo S.F. High recurrent rate of multicentric papillary thyroid carcinoma // Ann. Surg. Oncol. 2009. Vol. 16. Р. 2609–2616.

32. Wada N., Sugino K., Mimura T. et al. Pediatric differentiated thyroid carcinoma in stage I: risk factor analysis for disease free survival // BMC Cancer. 2009. Vol. 9. Р. 306.

33. Bargren A.E., Meyer-Rochow G.Y., Delbridge L.W., Sidhu S.B., Chen H. Outcomes of surgically managed pediatric thyroid cancer // J. Surg. Res. 2009. Vol. 156. Р. 70–73.

34. LaQuaglia M.P., Black T., Holcomb G.W. et al. Differentiated cancer: clinical characteristics treatment and outcome in patients under 21 years of age who present with distant metastases; a report from the Surgical Discipline Committee of the Children’s Cancer Group // J. Pediatr. Surg. 2000. Vol. 35. Р. 955–959.

35. O’Gorman C.S., Hamilton J., Rachmiel M. et al. Thyroid cancer in childhood: a retrospective review of childhood course // Thyroid. 2010. Vol. 20. Р. 375–380.

36. Beasley N.J., Lee J., Eski S. et al. Impact of nodal metastases on prognosis in patients with well differentiated thyroid cancer // Arch Otolaryngol Head Neck Surg. 2002. Vol. 128. Р. 825–828.

37. Leboulleux S., Baudin E., Hartl D.W., Travagli J.P., Schlumberger M. Follicular cell-derived thyroid cancer in children // Horm Res. 2005. Vol. 63. Р. 145–151.

38. Chow S.M., Law S.C.K., Mendenhall W.M., Au S.K., Yau S., Lau W.H. Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine // Pediatr Blood Cancer. 2004. Vol. 42. Р. 176–183.